We collaborated with industry leaders across the drug supply chain throughout the development of Pulse to ensure that our solution meets industry needs. From large and small dispensers, wholesale distributors, manufacturers, and our member boards of pharmacy, these leaders have provided valuable perspectives. Learn more about our pilot programs, which have been invaluable to developing a secure, streamlined DSCSA-focused solution that meets industry needs. Explore our recent reports.
In advance of DSCSA implementation, this pilot identified solutions across several areas to address gaps in data exchange, trading partner communications, regulator and dispenser authorization, and mapping various identifiers.
Throughout this pilot, we hosted collaborative workshops for trading partners and regulators, as well as explored use cases and identified findings and gaps to meet DSCSA requirements.
This pilot explores the facilitation of decommissioning serial numbers as a foundational step in further preventing and detecting counterfeit medicines in the supply chain.